The Burgeoning Burden of Respiratory Syncytial Virus Among Children

Publisher： Bentham Science Publishers

E-ISSN： 2212-3989|12|2|92-97

ISSN： 1871-5265

Source： Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol.12, Iss.2, 2012-04, pp. : 92-97

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Respiratory syncytial virus antiviral agents

By Prince G.A.  

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 6, 1999-06 ,pp. : 753-762

Informa Healthcare

Access to resources Recommend Favorite

Development of respiratory syncytial virus vaccines

By  

Inpharma, Vol. 1, Iss. 1429, 2004-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Evaluation of the Safety of Palivizumab in the Second Season of Exposure in Young Children at Risk for Severe Respiratory Syncytial Virus Infection

By Lacaze-Masmonteil T.  

Drug Safety, Vol. 26, Iss. 4, 2003-01 ,pp. : 283-291

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Palivizumab for Respiratory Syncytial Virus Prophylaxis in High-Risk Children: A UK Analysis

By Nuijten Mark J.C.   Wittenberg Wolfgang   Lebmeier Maximilian  

PharmacoEconomics, Vol. 25, Iss. 1, 2007-01 ,pp. : 55-71

Adis International

Access to resources Recommend Favorite

Impact of Respiratory Syncytial Virus: The Nurse's Perspective

By Bracht Marianne  

Drugs in R&D, Vol. 11, Iss. 3, 2011-09 ,pp. : 215-226

Adis International

Access to resources Recommend Favorite